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Retinoids exert their effect through ligand-depen-
dent transcription factors, retinoic acid receptors 
(RARa, (3, and y) and retinoid X receptor (RXRa, (3, 
and y), which belong to the superfamily of steroid/ 
thyroid/vitamin D3 nuclear receptors. Using a sub-
traction hybridization approach, we have identified a 
cDNA sequence, Tazarotene Induced Gene 1 (TIG1), 
w hich is highly upregulated in skin raft cultures by an 
RAR{3/y-selective retinoid AGN 190168 (tazarotene/ 
ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)-ethynyl] 
nicotinate), which is effective in the treatment of 
psoriasis. The retinoid-mediated upregulation in the 
expression of TIG1 was confirmed by Southern and 
N orthern analyses. Upon sequencing, TIG1 was 
found to be a novel cDNA which encodes a protein of 
228 amino acids whose sequence suggests that it is a 
R etinOiC acid (RA) and its synthetic ana.logs exert their biological e ffects thro ugh two fa milies of nuclear receptors, retin o ic acid recepto rs (RARO', f3, and )'), and retinoid X receptor (I"U<.RO', f3. and )'), which belong to th e supel' fa mily of steroid / 
thyroid hormone nuclear receptors (Chambon, 1994; Man ge1sdorf 
e/ ai, 1994). RARs and l"l..XRs upregulate gene expression by 
binding to the pro moter regions of retinoid responsive genes as 
transcriptionally active RAR-I"l..XR heterodimers (Nagpal el ai, 
1993) or RXR homodimers (Zhang el fll, 1992). Although retino ids 
are therapeutica lJ y effective in the trea tmen t o f vario us dennato-
logical diseases (Peck el (/1, 1994; Boe hm e/ (/1, 1995), their m ode of 
action in skin is poorly understood. A number of retinoid-induced 
genes have been iden ti fi ed in various systems (Mangelsdorf el ai, 
1994), but cellular retinoic acid-binding protein n (CRABP II) is 
the o nly m arker known to be indu ced by RA in normal skin (Elder 
et ai, 1993). CRABP II is dow111'cgulated by RA in submet'ged 
keratinocyte cultures (Elder and Cromie, 1993), however, indicat-
ing that its promoter contain s anothe r enh ancer function, w hich 
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transmembrane protein with a small N-terminal in-
tracellular region, a single membrane-spanning hy-
drophobic region, and a large C-terminal extracellu-
lar region containing a glycosylation signal. We 
demonstrate that TIG1 is also upregulated by AGN 
190168 in skin raft cultures prepared from psoriatic 
fibroblasts and normal keratinocytes and in primary 
fibroblast and keratinocyte cultures. We also show 
that TIGl is upregulated by retinoic acid receptor but 
not by retinoid X receptor-specific synthetic retin-
oids. Finally, we demonstrate that TIGl is induced by 
AGN 190168 in psoriatic lesions during the course of 
clinical treatment of the disease. Kcy IVOl,ds: l'ctilloids/ 
RAR/psOl'iasis/sllbtl'activc "jlbridiz atioll. ] Invcst D CI'matol 
106:269-274, 1996 
under certain conditio ns dominates the enh ancer action of its 
retinoic ac id response elem ent. T lus notion is further strengthened 
by the observation that CKAB P If is overexpressed in psoria sis 
(Didielj ean el ai, 1991), a discase that re ponds to retinoid treat-
ment. T herefore, CRABP II does not appea r to be an efficacy 
m arker of retinoid action in diseased skin, and it m ay possibly 
contribute to the pathogenesis of psoriasis by seq uestering RA in 
the cytoplasm . In order to understa nd the m echanjsm of retino id 
actio n in diseased skin, we system atica lly looked for the genes 
indu ced by a novel .RAK,B/),- selective re tinoid , AGN 1901.68 
(tazarotene) (Nagpal el fll , 1995) , which is topically effective for the 
treatment of psoriasis (Esgleyes-Ribot e/ ai , 1994). By sub tr active 
hybridiza tion in 3-dimensional cul tures of skin (skin rafts) , we have 
identified a novel RAR.-respo nsive gene, tazarotene-induced gene 
1 (TIG1), w hk h is induced, in various 2- and 3-dimensional 
cul tures of skin cells, in a retinoid-dependen t m anner. We also 
demonstnlte that T JG1 is indu ced by the re tinoid AGN 190168 in 
psoriatic les ions, w here retinoids exert their th erapeu tic action. 
T hu s, T IGl is a true retino id-responsive gene and appears to be a 
marker of retinoid therapeutic action in skin . 
MATEIU ALS AND METHODS 
Skin Raft Cultures N ormal skin raft cultures (Model ZK 1300, Ad-
va nced Tissue Sciences, CAl are 3- dim ension al hllman skin tissues that have 
dermal . epiderm al, and corneal laye rs. T h ese skin rafts were made by th e 
l11anu f;,cturer by sceding neonatal fibroblasts (poo led from 10 dono rs) o nto 
a nylo l1 nl csh \vhich gave rise to a dcrl11al t iss ue. Kcrati nocytcs seeded o n 
top of the derma l tissue d ifferentiated into an epidermis consistin g of 
1l1ultilaycrcd stratunl corn e UITI. basa l. spino us! and granular layers. 
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Subtractive Hybridization Skin raft cultures (Advanced T issue Sci-
ences) were kept overnight in serum-fi'ee maintenance medium (Advanced 
Tissue Sciences) and either mock-treated or treated with AGN 1 <)0168 
(1 fLM) on da y 1 and 3, and harvested on day 4 by directly immersing them 
in guan idine thiocyanate so lution for total RNA preparation. eDNA 
prepared from AGN 190168- treated skin raft cultures was direcLiona lly 
cloned into Sal I-N ot I sites of pSPORT -I (Life Techn ologies Inc.) and 
single-stranded DNA (ss DNA) was prepared fi'om 10" transformants with 
the help of M 131(07 (> I X 10" pfu/m l, life Technologies Inc.) (Li et nl. 
1994). Another directiona l cDNA library was constructed in SaIl -Not I sites 
of pSPOR T -2 (Life Technologies Inc.) using cDNA from mock-treated 
skin raft cultures, linearized with SaIl and ill "iim transcribed in the presence 
of biotin-14-CTP as described (li "I ,Ii, 1994). pSPO ltT- '1 ss DNA was 
blocked with a Not I-o ligo primer 5' -GCGGCCGCCCT 15-3' by incubating 
at 70· C for 20 min with 600 fLM dTTP 'lIld Tag DNA polymerase. Poly 
dA-blocked ss DNA (600 ng) was hyhridized with biotinylnted RNA (80 
fLg) in 2 X hybridization bulier (80')1" fonnamide. 100 111M N-2-hydroxy-
ethylpipcrazine-N' -2-ethanesulfonic acid , pH 7.5, 2 mM ethylenediamine 
tetraace tic acid, and 0.2% sodium dodeC)'1 sulfate) for 24 h at 42°C with 
shaking (200 rpm). The contro l experiment conta ined all the components 
except biotin ylatcd RNA. After hybridiz,ltion , slTeptavidin (25 fLgl was 
added and the mixture was incuba ted at room temperature (5 min). 
Comill on ssDNA-RNA sequences were removed by phenol/chloroform 
ex traction (five times) . unhybridized ssDNA was pn:cipit"ted and clectro-
porated into DH 12S (life Technologies Inc.) cells. 
Retinoids All trans-retinoic acid waS purchased commercially (Sigma 
Chel1lical Co .. St . Louis, MO). AGN 1901 68 (tazarotene), AGN 190299 
(6-[2-(4,4-dimeth ylthiochroman-6-yl)] nico tinic acid) . AGN 19012 1 (1£)-
4-[4-(2,6,6-tri methyl-l-cyclol",xenc-l-yl)-3-buten-l -ynyI] benzoic acid), 
AGN 191 183 (TTNPB; 4-[2-(5,6,7,8-tctrahydro-5,5,8.8-tetramethyl-2-
naphtllalenyl)-2-propenyl]bcnzoic acid), SR 11 2 17 (4-[I -(5,6,7,8-tetrahydro-
5,5.8,8-tetramethyl-2-n"pllthalenyl)-2-methyl- 'I-propenyl )benzoic acid), and 
SR '1 '1237 (2-[ 4-carboxyphenyl]-2- l5,G, 7,8-tcll·n bydro-5.5,8,8-tetramethyl-2-
naphth,,'enYII- I,3-dioxolalle) were synthesized in the Deparllllellt of C hemis-
try, R.etinoid R.esearch. All ergan Inc. (Irvine, CAl. 
Southern Hybridization For Southern hybridiza tion , Sa l I-Not I-di-
gested cDNA clones were electrophoresed in duplicate . transferred to 
nytran , ;lIld probed with Inbeled total eDNA from either mock-tJ:eated or 
AGN 1901G8-treated skin rafts. Probes were hybridi zed overnight (42°C) 
and the membranes were washed (0.1 X SSPE/ l % sodium dodecyl sulfate) 
at 65°C for 45 min. 
Northern Hybridization For northern hybridization . tota l ItNA (10 
l..I.g) was e lectrophoresed on 1 % aga rose- 'I . I M formaldehyde gels. trans-
fe rred to nytra" and probed with Inbclcd eDNA probes at 42°C forI 8 h . 
Tbe most stringent wash was at 65 °C in 0.1 X SSPE/ l % sodium dodecyl 
su lf.,te for 30 min. 
Preparation of Psoriatic Skin Raft Cultures Human cul tured psori-
atic fibrob lasts (200 .000 ce ll s) obtained fi'om pSOliatic lesional punch 
biopsies were mixed with type I co llagen (3.5 mg/ ml , Collaborative 
Biochemicals Products. Bedford, MA) , neutrali zed with NaOH ('I N) and 
plated in 24-wcll plntes. Human prim"r)' foreskin keratinocytes (500.000 
ce lls/well ) were layered aftcr 24 h on top of the coll<l gen laye r. The collagen 
gels containing fibroblasts and kcratinocytes were rai sed to tbe il ir-liquid 
interf'lce after 24 h as desclibed (Be ll ('/ nl. 1 <)79) . Itafts were maintained ill 
FAD mediulll supplemented with fetal bovine serull1 (1 U'Y.) , hydrocortisone 
(400 ng/ml) , cholera toxi.n CI a- III M, Sigma), ep idermal growth factor (10 
ng/I11I), fi.lI1gibact (1%), adenine (0.089 111M). and insulin (0.105 IU/m l), as 
described (Duvie ('/ nl, 1994). grown fo r 10 da ys <lnd used for experiments 
on day 11. Psoriatic rafts were kept overnight (day 0) in sefllm-frcc 
medium, trea ted with rctilloids on day 1 and day 3 ('l fLM each) and 
harvested on da y 4 by fIxing in paraformaldeh yde (4
'
1.,). 
PCR Amplification of TIGl in Cultured Keratinocytes For the 
iso lation of keratinoeytcs. fresh human foreskins were washed in ethanol 
(70%) for lO s fo llowed by two washings in keratinocyte growth medium 
(Clonerics) . Foreskins were cut in to small pieces (4-111111 diameter). incu-
bated with trypsin (0.05%. Life Technologies. Inc. ) for 24 h at 4 · C . 
centrifuged (1000 rpm) for 6 min , filtered through a nylon mesh membrane, 
and cultured in kerarinocyte growth medium contailling 10% fetal bovi ll e 
se rum. The media was replaced after 3 da ys with keratinocyte growth 
ITIcd iuI11 \>vith o ut fe tal bovine sc nlln ~ and kcratinocytcs were 111aintaincd in 
serum-free media and treated with AGN 190 168 (1 fLM) after three passages 
fo r 24 h. Total RNA was iso lated Ii'om AGN 190 16B-trmlted and mock-
treated cultures by guanidine th iocyanate (Prom ega) method, reverse 
transcribed lI sing o ligo(dT) and polymerase chain rcaction (PCIt)-ampli ficd 
using T IG I alld glyce raldehydc-3-phosphatt: dehydrogenase (GAPDH) 
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(intern al control, C lontech) primers. T IG1 message was amplified using 
oligo pairs 5'-TCAGGTTTTTCTTACCCACTG-3' and 5 ' -ACCTGCll-
TACAAGCAAATGA-3'. PCR products ( 10 fLI) were removed aftcr every 
three PCR cycles starting fi'om 12 to 36 cycles as shown in Figs 3A and B. 
The PC R products were e lectrophoresed 0 11 agarose gel (2%) and viewed 
0 11 a ultra vio let transi llul11inator after ethediul11 bromide sta illing. 
III Situ Hybridization III S;III hybridization was performed on paraffu,-
embedded paratorma ldehyde-fixed sections using Genius kit (BocriJlger 
Mannheim , Indianapo lis. IN). Proteinase K (2.5 fLg/m l) digestion was 
carried on for 3U min and hybridization with digoxigenin label cd anti-sellse 
probe (0.4 ng/ ml) was performed at 44 · C. Nonspecific binding was blocked 
w ith normal sheep serum (2%), and specifi c binding was detected by 
incubation (3 h) with alkaline phosphatase conjugated anti-digoxigcnin 
antibody followed by 4-h incubation with nitrobluc tetrazolilll11 substrate at 
37°C. Sense probes were used in para llel as negative controlS and showed 
no b<lckground staining. 
RESULTS 
Identification of a Novel Retinoid-Responsive Gene, TIG1 , 
by Subtraction Hybridizatioll AGN 190168, an RAR{3/'y-
selective retinoid, is efFec tive ill the tl:eatmcnt of psol-ias is (Esgleyes-
R.ibot cf ai, 'J 994), " hyperp rolifenltive and inflammatory skin 
di sease. Usin g a subtra ction hybridiza tion procedure (Li et ai , 1994) 
fOl' th e isol ation of AGN 190168-indu ced genes in 3 -dimensional 
skin raft cu ltures , we have identified a cDNA sequence which was 
upregulated b y retinoid treatm e nt. Southern ana lys is of the sub-
tracted cDNA clones sh owed th e upregulation of#B27 and #B1 6 
in n ytra n blots probed with labeled total cD NA from AG 1 
1901 68 -treated c ul tures compared with the control where eDNA 
fr'om mock-treated raft c ultures was used (Fig 1A). The upregula-
tion of#B27 and #B16 was furth e r conftrmed by Northern analysis 
of tota l RNA from mock-treated and AGN 190168-treated skin 
raft cu ltures and 32P_Iabeled #B27 a nd #B 16 cDNAs (Fig 1 C,D) . 
The blot was probed w ith labeled GAPDH cD NA to ensure that 
equa l quantity of control and retinoid-treated RNA was used in the 
Northern ana lys is (Fig 1B). Upon sequencin g, #B27 and #816 
were found to be identical and h e reafter w ill be referred to as TIGl. 
T IG 1 was 862 bp in le ngth, contained an open reading frame from 
37 to 723 bp and coded for a putative prote in product of228 ammo 
acids (Fig 2A) . It h ad a pol y A signal (5'-AATAAA- 3') at the 
826-bp position (Fig 2A). Homology search es fi'om DNA (Gen-
Bank and EMBL) and protein (Swiss-Prot) databascs did not show 
any ide ntity to known DNA and protein seq u e nces, thus indicating 
TIGl to be a new cDNA seq uence . The putative protein sequence 
ofTIG1 contained a hydrophobic stretch of 19 amino ac ids (amino 
ac ids 24 to 45) and a g lycosy lation signa l (NVT, amino acids 142 to 
144) seq uen ce and a h yaluronic acid bindin g motif (KCSAR VFFK 
am in o ac ids 125 to 133) (Fig 2A,B) . T h erefore . T IG1 appears to 
code for a transmembrane protei n w ith a long extracellul ar domain 
of194 amino ac ids, a membrane-spanning region of 19 amino acids 
and a small intra cellular regio n of 15 ami n o acids. The hydropathic 
proft le of TI.G I resembles that of CD38 Oackson and Bell , 1990). 
another reti noid-respon sive gene prese nt in immune cells (Malavasi 
cf ai, 1994). CD38 also has a sma ll intracellul ar domain (21 amino 
ac ids), a single transmembrane region and a long extracellular 
region Uack son a nd B ell , 1990) . T hu s, T IGl might b e structurally 
related and ana logous in function to CD38 since both are retinoid 
respon sive and disp lay h omology in th e ir h yd ropathic profiles. 
T IG1 was also uprcgul ated by AGN 190'168 in primary cu ltured 
keratin o cytes (Fig 3A) and d e rmal fibroblasts (Fig 3e). GAPDH 
control s for RNA s are shown in Fig 3B and D for keratinocytes 
and fibroblasts , respectively. T IG1 was also induced by all -trans 
retinoie acid in dermal fibroblasts (Fig 3 C) and skin raft cultures 
(data not shown) , thus d e monstrating it to be a classical re tinoid-
respon sive gene . 
TIG1 Is an RAR but Not an RXR Agonist-Responsive Gene 
AGN 190168, 190121 , and 191183 (TTNPB) activated gene 
exprcssion on ly through RAR.s and not throu g h RXRs (Nagpal el 
ai, 1995) . In co ntrast, SR 11217 and 11237 activated gene expres-
sion through RXRs (Lehmann ci ai, 1992) and not through RARs 
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Figure 1. Screening and identification of AGN 190168 induced 
cDNA clones. Subtracted cDNA cloncs were scrcened fo r their AGN 
190168 up regulation by Southern ana lysis (A) and they were fin ally 
confirmed by Northern hybridiza tion (B-D). A) Two clones (B27 a/ld B'I6) 
which showed uprcgulation are indicated by arrows. B-D) Tota l l'lNA (10 
JLg) form mock-treated (CONTKOL) and AGN 190168-trcated skin raft 
cultures was sul:(j ected to Northern hybridization. GAPD H (B) . # 27(C), 
and #16 (D) sequences were detected with hlbeled cDNA probes. 
(our unpubJj sh ed resul ts). Furthe r, AGN 190168 and AGN 190121 
were RARt3/)' selective and exh.ibited on ly weak tran sactivatio n 
through RARG~ (N'l gpa l et aI, 1995 ). To d e term in e the receptor 
specificities ofTIGl expression , prim ary cul tmed keratinocytes w ere 
trea ted with RAR-specific (AG N 190168 , 190121, and 191183) 
o r RXR-specific (SR. 11217 and '11 237) syn thetic re tino ids (Fig 
3G). Furthe r, T IGI was not indu ced by RXR-specific synthe tic 
retinoids in skin raft cultures (data n ot shown) . The R AR- specific 
retinoids induced T IGl expression , w h ereas the two R X R-
specific re tinoids failed to significantly induce T I G1 , th us d emon-
stra ting th at th e induction o f T ICl is m edia ted thro ugh RAR but 
not by RXR. agonist-dependen t signa l transduction pathways. 
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1 CCACGTCCGGGG'l'GCCGAGCCMCT"M'CC'rGCG'ICCA'I'GCjI,GCCCCGCCQGCAACGGCTG 60 
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61 CCCGCTCCCTGGTCCGGGCCCAGGGGCCCGCGCCCCACCGCCCCGCTGC'OCGCGCTGC'TG 120 
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541 1\lv\AAC(,CCTI'GG}lJv\TAGTCAGCJ\TACC'TGAT.l\A1'CATGGACATATTGA't'CC~ 600 
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601 AGj~.C'I'CATC'I'GGCAT1.'TGGc..-rITCC'TI'GGl\J\GC'IC'rTACG'I'GJ\'TGTGGGAAA'T'GACAACA 660 
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Figure 2. Nucleotide sequence, putative protein sequellce and 
hydropathic profile ofTIG1. TIG'I (#B27 and #B 16) eDNA clones were 
sequenced and analyzed by MacDNASIS (Hitachi) program fo r nucleotide 
and protein homologies frolll Gen.Bank. EMBL, and Swiss-Prot database. A) 
Nucleotide and puta tive protein sequence of T IG1 as obta ined fro 111 Our 
sub tracted library arc shown. T he GcnBank accession number for the 
cDNA sequence is U27185. B) Kyte-Dooli ttle hydrophobicity plot ofTIG1 
showing I;ydrophobicity ()' axi s) ng"inst amin o acids (x axis) is presented. 
I~cgi on s of the protein greater than + 0.50 "rc predicted to be membrane 
embedded (MacDN AS IS). T IG1 sequence w"s obtained by doublc-
stranded DNA sequencing of ciones B27 and B 16 (Fig lA) by an automated 
DNA sequencer (Sequetech, CA l · 
TIGl Is Upregnlated in Psoriatic Rafts in a Retilloid-
Dependent Manner Psoria ti c fibrobla sts have bee n shown to 
induce hyp erprolife ratio ll of norma l ke ratinocytes (Saiag e/ aI, 
1985). Psoriatic skin raft cultures prepared fi'om psoriatic le siona l 
fibrob lasts and n o rmal keratin ocytes were eith er m ock-treated or 
treated w ith AGN 1901 68 o r its acid fi'om AGN 190299 (6-[2-(4,4-
dimethylthio chroman-6-yl)] nicotinic ac id). Nor thern analysis o f 
con tro l an d treated RNA s revea led the in du ctio n ofTJG1 b y both 
AGN 190168 and AGN 190299 (Fig 3E) in comparison with 
GAPDH (Fig 3r) . We furth e r de m o n str ated the re tin o id m ediated 
upreg ulatio n ofTIG '1 in psoriatic rafts by ill sitll h ybridization usin g 
digoxigenin- Iabe led T IG I anti-sense RNA. In m ock-treated p sori-
atic rafts, T IG l was ex pressed only in the suprab asa l layers of the 
epide rmis (Fig 4B) . T reatm en t of rafts w ith AG N 190168 (Fig 4C) 
o r AGN 190299 (Fig 4D) induced the expressio n ofTIG 1 in all th e 
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Figure 3. TIGl is induced by rctinoids in 
primary keratinocytes, dermal fibroblasts, 
and psoriatic skin raft cultures. A,B) RN A 
from mock-treated (CONTROL) and AGN 
190168-treated keratinocytes was reverse tran-
scribed and PCR amplified using T IGI (A) and 
CAPDH (B) (CIontech) oligo primers. C,D) 
Total RNA (10 IJ..g) from mock-treated (CON-
TROL), AGN 190 168- or RA (1 IJ..M each for 
24 h)-treated primary fo reskin dermal fibro-
blasts was subjected to Northern hybridization. 
TIGl (C) and GAPDH (D) sequences were 
detected with 32P_Iabeled eDNA probes pre-
pared by ra ndom priming. Hyblidized blots 
were exposed fo r 36 h. E,F) AG N 190168 and 
190299 induce T IGl in skin raft cul tures pre-
pared from psoriatic fibroblasts ,md normal 
keratinocytes. Tota l RNA (10 IJ..g) from mock-
treated (CONTROL). or AGN 190168- or 
AGN 190299-treated psoriatic raft cultures was 
subj ected to Northern hybridization. Psoriatic 
skin rafts were treated with retinoids (1 IJ..M 
each) on day 1 and day 3 and harvested 011 day 
4. T IC I (E) and GAPDH (F) seq uences were 
detected in tota l IW A obta ined frol11 control or 
retinoid-treated psoriatic skin rafts with labcJed 
cDNA probes and the hybridization blots were 
exposed for 36 h. C) RXR-specific compounds 
do not induce T IGl expression. Total RNA (10 
IJ..g) from mock-trea ted and retinoid-treated 
(24 h treatment with 1 IJ..M retinoid) keratino-
cytes was subjected to Northern hybridization. 
TICI and GAPDH sequences were detected 
with labeled cDNA probes. 
A 
TlCI 
la yers of e pide rmis, thus further confirming the results obtained 
with N o rtbern hybridization (Fig 3E» . T reatment of raft sections 
with labe led sense T IGI RNA did not show any sta ining (Fig 4A) . 
Topical Tazarotene (AGN 190168) Induces TIG1 Expression 
in Psoriatic Lesional Biopsies In o rder to demonstrate the 
induction of T IGI in psoriatic patients after AGN 190168 treat-
m ent, patients (n = 20) with long- standing bilateral plaque psoriasis 
were treated twice daily with AGN 190168 (0.1% gel) in a clinical 
study for up to 8 weeks. Skin punc h biopsi es were taken on day 0 
(before the start of treatment), day 3 (after 3 d of application of 
AGN 190168), and day 14 (afte r 2 wk of treatment with AGN 
1901 68) . [II silll hybridization usin g digox igenin-Iabe led TIG1 
antise nse RNA showed little staining for T IGI mRNA in 110nle-
sio nal psoriatic skin (Fig 4F) as well as in day 3 mock-trea ted 
lesio nal skin (Fig 4G). In contrast, T IG1 was readily observed 
e ither at day 3 o r 14 in AGN 190168-treated psoriatic lesio ns. A 
typical ill sit ll demonstrating induction ofTIGl in a day 3 biopsy is 
shown (Fig 4H). Treatm ent of psoriati c les ion section with sense 
digoxigenin-Iabeled TIG1 RN A probe did not show any staining 
(Fig 4E). T IGl upregulatio n in psori atic lesio ns was also confirmed 
by reverse transcriptase PCR in p ooled b iopsies from resp onde rs 
(n = 16) a fte r 2 wk of treatmen t with AGN 190168 (data not 
sh own). T hus, the upregulation of T IG 1 by AGN 190168 is 
o bserved not o nly in 2- and 3-dimensional cultures of kera tinocytes 
and fibroblasts but also in the epide rmis of psoriatic p atients treated 
with AGN 190168. Although TIGl is induced by AGN 190168 in 
cultured primm)' fibroblasts (Fig 3C,D), it is expressed in psoriatic 
lesional skin after AGN 190168 treatment mainly in epidermal 
ke ratinocytes and not significantly in dermal fibroblasts (Fig 
4G,H). Altematively, the lack of induction of T IG 1 in d ermal 
fibro blasts ill "i"o could be due to the inefficient pe netration of the 
topically applied retinoid. 
DISCUSSION 
In this article, we describe the identification of a new retinoid-
responsive gene, T IG1 , by a subtraction hybridization approach to 
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determin e genes regulated by a n anti-psonatlc retinoid AGN 
190168. T IG l is induced in an R A R -specific manne r in a variety of 
human skin-re lated sys tems analyzed i.n this r epo rt (Figs 1, 3, 4). 
We a lso demonstrate that T IG 1 is not significantly detected in 
Ilo nles ional or lesional psoriatic skin (Fig 4F, G), it is significantly 
induced during the clinica l treatment of psoriasis by AGN 190168 
(Fig 4H) , suggesting that it might playa role in the anti-psoriatic 
m echanism of action of retinoids. Furthe r, TTGl is not induced by 
RXR-specific retinoids, whereas it is induced by all the RAR-
specific retinoids tested (Fig 3 G), although human keratinocytes 
contain both RARs and R X R s (Fisher el a/, 1994). Tlus observation 
is in concord an ce with other o bservatio ns that RXR-specific 
compounds are silent in skin and other sys tem s with respect to a 
variety of bio log ical effects. These e ffects include resolution of 
utric uli and transepide rmal water loss in rluno mouse skin (Gencli-
m enico e/ a/, 1994), inhibition of 12-0-tetradecanoyl-phorbol-13-
acetate-induced omitlune decarboxylase activ ity in hairless mouse 
skin (our unpublished data) , downregulatio n of migratio n inhibi-
tory f.1ctor-re lated protein- 8 (MIU-8) and skin-de rived anti-
leukoproteinase (SKALP) in skin raft and keratinocyte cultures (our 
unpublish ed data), diffe rentiation ofF9 cells to parie tal endodennal 
cells, laminin inductio n in F9 cells (Gendimenico el a/, 1994) and 
inhibition of growth of breast cancer cell lines (She ikh et a/, 1994) . 
Since RARs function ill "ilm (Le id el a/, 1992) and il/. "ilIO (Nagpal 
e/ a/, 1993) as RAR.-RXR h eterodime rs, it seems that for TIGl 
activatio n , occupation of only the RAR ligand binding site of the 
he te rodime r is required and occupation of the RXR site is eitller 
n ot possibl e or is silent as sugges ted for a DRS element (Kurokawa 
el a/, 1994). Also, the RXR homo dimer pathway (Zhang el ai, 
1992) is either absent in keratinocyte system s or does not lead to 
TIGI induction . Since retino id-dependent activation events in-
volve R AR -RXR heterodime rs (Cham bon , 1994; Mangelsdorf et 
a/, 1994), T IGI must get ac tiva ted by RAR-RXR he terodimers in 
response to RAR agonist with RXR actin g as a partner to facilitate 
the DNA binding o f RARs in an RXR agonist-inde pendent 
manner. Thus, TIG1 appears to be a specific RAR-responsive gene 
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Figurc 4. Rctinoid-dcpcndcnt induction of 
TIG 1 in psoriatic rafts and lcsional psoriatic 
skin biopsy. [II sjlll hybridization using digoxigenin 
labeled anti-sense TIGl RNA probes was performed 
in psoriatic skin rafts after mock-treatment (B) or 
treatment with AGN 190168 (C) or AGN 190299 
(D). AGN 190168-trcated psoriatic raft probed with 
sense digoxigenin labeled probe is also shown (A). 1/1 
Sit ll hybridization using digoxigenin-labeled anti-
sense T IGI probe was also performed in nonlesional 
psoriatic skin (F) . lesional psoriatic skin mock-treated 
for 3 d (G), and lesional psoriatic skin after treatment 
with AGN 190168 for 3 d (1-1). [II sitll control w ith 
retinoid-treated psoriatic skin probed with digoxige-
nin-labeled sense T IGI probe was also perfonned 
(E). Scale bars: A,B,D-H) 100 ILI11; C) 50 ILm . 
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which may be a m olecular marker of retinoid therapeutic efficacy 
and hence useful in the systematic development of retinoids for skin 
diseases such as psoriasis. In contrast, although CR.ABP II has been 
suggested as an inducible marker of retinoid action in normal skin 
(Elder el ill, 1993), it is expressed at high levels in psoriatic skin 
(Didierjean et ai, 1991) and it is downregulated by RA in sub-
merged keratinocyte cultures (Elder and Cromie, 1993). 
It is interesting to consider the potential functions ofTlG1 and its 
role in RAl:t-mediated biology. Since it appears to be a transmem-
brane protein and contains a putative hyaluronic acid binding motif, 
it might function as a cell adhesion molecule whose expression on 
the cell surface might lead to better cell-cell contact and reduced 
proliferation . Another important phenotype of psoriasis is the 
presence of inAammatory cell infiltrate in the epideremis and 
dermis. How TIGl might inhibit the inAammatory component 
associated with psoriasis, is presently unknown and the exact 
answer must await more understanding of the biology associated 
with T IG1. It is particularly interesting to consider the similarity 
that ell."ists in the hydropathic profiles of TIG1 and CD 38 in spite 
of the lack of homology at the nucleotide and amino acid levels. 
CD 38, w hich is acutely upregulated by rctino ids in immune celis, 
has been shown to have cyclic ADP-ribosyl (cADPR) cyclase , 
cADPR hydrolase, and N AD + glycohydrolase activities . Further, 
CD 38 binds ill IJilro to hyaluronic acid and like TIG1 contains a 
hyaluronic acid binding motif in its large extracellular domain 
(Nisluna et ai, 1994) and has been implicated in cell-cell adhesion 
functions (Malavasi el ai, 1.994). Thus, molecules such as T IGl and 
CD 38 might play some general but not as yet well-understood 
roles in RAR biology in a cell-specific manner. The importance of 
TIGl in RAR-mediated physiological functions and in the thera-
peutic efficacy of retinoids in responsive diseases such as psoriasis 
would be clear only after elucidatio n of the exact function ofTIG1. 
Finally, it should be noted that in spite of the general understanding 
that has prevailed since the discovery of the re tinoid nuclear 
receptors that retinoids are gene regulatory molecules, TIGl is the 
first novel gene to be identified specifically because of its retinoid 
responsiveness. 
Hie thallk S. T lwchcr allil S. Frialll fo r Ihe gCllerollsl), proIJiilillg I","w" prill/ar)' 
foreski ll kemlilloC),I"S alld fibroblaSTs. I'Ve also rlwll k Drs. L. W heeler, M. 
Roselllhalc, S. T hacher, ami E. K/cill./or crilical IT"ie//! of lite IIwIIl/script. 
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